Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Leisa R. Watson; Thomas E. Lew; Lucy C. Fox; Amit Khot; Carrie van der Weyden

doi:10.1080/10428194.2022.2118537

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Leisa R. Watson
, Thomas E. Lew
, Lucy C. Fox
, Amit Khot
, Carrie van der Weyden

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	3217-3221
Number of pages	5
Journal	Leukemia and Lymphoma
Volume	63
Issue number	13
DOIs	https://doi.org/10.1080/10428194.2022.2118537
Publication status	Published - 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1080/10428194.2022.2118537

Cite this

@article{7ab7fd7874bf4e3584f2ae4d472eca52,

title = "Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma",

author = "Watson, \{Leisa R.\} and Lew, \{Thomas E.\} and Fox, \{Lucy C.\} and Amit Khot and \{van der Weyden\}, Carrie",

year = "2022",

doi = "10.1080/10428194.2022.2118537",

language = "English",

volume = "63",

pages = "3217--3221",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor \& Francis",

number = "13",

}

TY - JOUR

T1 - Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

AU - Watson, Leisa R.

AU - Lew, Thomas E.

AU - Fox, Lucy C.

AU - Khot, Amit

AU - van der Weyden, Carrie

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85137800567

U2 - 10.1080/10428194.2022.2118537

DO - 10.1080/10428194.2022.2118537

M3 - Letter

C2 - 36070587

AN - SCOPUS:85137800567

SN - 1042-8194

VL - 63

SP - 3217

EP - 3221

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 13

ER -

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

UN SDGs

Access to Document

Other files and links

Cite this